Abstract
In the past years bacteriophages have been employed in a wide array of applications including therapy of bacterial infections, genetic research and the discovery of specific target binding proteins. More recently they have been proposed as delivery vehicles for peptides/proteins and DNA in the development of phage delivered vaccines and for gene therapy. Because of their efficacy, low cost, safety and physical stability, bacteriophages have represented and still represent a relevant and promising tool in this diverse range of fields. The aim of this chapter is to review studies where filamentous bacteriophages were applied as antigen and gene delivery vehicles and to emphasize their several potential applications in modern medicine and biotechnology.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Böckmann M, Drosten M, Pützer BM (2005) Discovery of targeting peptides for selective therapy of medullary thyroid carcinoma. J Gene Med 7:179–188
Buchwald UK, Lees A, Steinitz M, Pirofski LA (2005) A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice. Infect Immun 73:325–333
Burg MA, Jensen-Pergakes K, Gonzales AM, Ravey P, Baird A, Larocca D (2002) Enhanced phagemid particle gene transfer in camptothecin-treated carcinoma cells. Cancer Res 62:977–981
Chung YS, Sabel K, Kronke M, Klimka A (2008) Gene transfer of Hodgkin cell lines via multivalent anti-CD30 scFv displaying bacteriophage. BMC Mol Biol 9:37
Clark JR, March JB (2004) Bacteriophage-mediated nucleic acid immunisation. FEMS Immunol Med Microbiol 40:21–26
Clark JR, March JB (2006) Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Trends Biotechnol 24:212–218
Clark JR, Bartley K, Jepson CD, Craik V, March JB (2011) Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B. FEMS Immunol Med Microbiol 61:197–204
De Berardinis P, Sartorius R, Fanutti C, Perham RN, Del Pozzo G, Guardiola J (2000) Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses. Nat Biotechnol 18:873–876
De Lorenzo C, Palmer DB, Piccoli R, Ritter MA, D’Alessio G (2002) A new human antitumor immunoreagent specific for ErbB2. Clin Cancer Res 8:1710–1719
di Marzo VF, Willis AE, Boyer-Thompson C, Appella E, Perham RN (1994) Structural mimicry and enhanced immunogenicity of peptide epitopes displayed on filamentous bacteriophage. The V3 loop of HIV-1 gp120. J Mol Biol 243:167–172
Eriksson F, Culp WD, Massey R, Egevad L, Garland D, Persson MAA, Pisa P (2007) Tumor specific phage particles promote tumor regression in a mouse melanoma model. Cancer Immunol Immunother 56:677–687
Eriksson F, Tsagozis P, Lundberg K, Parsa R, Mangsbo SM, Persson MA, Harris RA, Pisa P (2009) Tumor-specific bacteriophages induce tumor destruction through activation of tumor-associated macrophages. J Immunol 182:3105–3111
Esposito M, Luccarini I, Cicatiello V, De Falco D, Fiorentini A, Barba P, Casamenti F, Prisco A (2008) Immunogenicity and therapeutic efficacy of phage-displayed beta-amyloid epitopes. Mol Immunol 45:1056–1062
Fang J, Wang G, Yang Q, Song J, Wang Y, Wang L (2005) The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model. Vaccine 23:4860–4866
Gaubin M, Fanutti C, Mishal Z, Durrbach A, De Berardinis P, Sartorius R, Del Pozzo G, Guardiola J, Perham RN, Piatier-Tonneau D (2003) Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments. DNA Cell Biol 22:11–18
Greenwood J, Willis AE, Perham RN (1991) Multiple display of foreign peptides on a filamentous bacteriophage. Peptides from Plasmodium falciparum sporozoite protein as antigen. J Mol Biol 220:821–827
Hajitou A, Trepel M, Lilley CE, Soghomonyan S, Alauddin MM, Marini FC III, Restel BH, Ozawa MG, Moya CA, Rangel R, Sun Y, Zaoui K, Schmidt M, von Kalle C, Weitzmann MD, Gelovani JG, Pasqualini R, Arap W (2006) A hybrid vector for ligand-directed tumor targeting and molecular imaging. Cell 125:385–398
Hajitou A, Rangel R, Trepel M, Soghomonyan S, Gelovani JG, Alauddin MM, Pasqualini R, Arap W (2007) Design and construction of targeted AAVP vectors for mammalian cell transduction. Nat Protoc 2:523–531
Hashemi H, Bamdad T, Jamali A, Pouyanfard S, Mohammadi MG (2010) Evaluation of humoral and cellular immune responses against HSV-1 using genetic immunization by filamentous phage particles: a comparative approach to conventional DNA vaccine. J Virol Methods 163:440–444
Jelinek R, Terry TD, Gesell JJ, Malik P, Perham RN, Opella SJ (1997) NMR structure of the principal neutralizing dÝLerminant of HIV-1 displayed in filamentous bacteriophage coat protein. J Mol Biol 266:649–655
Larocca D, Kassner PD, Witte A, Ladner RC, Pierce GF, Baird A (1999) Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage. FASEB J 13:727–734
Larralde OG, Martinez R, Camacho F, Amin N, Aguilar A, Talavera A, Stott DI, Perez EM (2007) Identification of hepatitis A virus mimotopes by phage display, antigenicity and immunogenicity. J Virol Methods 140:49–58
Li XB, Schluesener HJ, Xu SQ (2006) Molecular addresses of tumors: selection by in vivo phage display. Arch Immunol Ther Exp 54:177–181
Li QY, Gordon MN, Chackerian B, Alamed J, Ugen KE, Morgan D (2010) Virus-like peptide vaccines against a beta N-terminal or C-terminal domains reduce amyloid deposition in APP transgenic mice without addition of adjuvant. J Neuroimmune Pharmacol 5:133–142
Malik P, Perham RN (1996) New vectors for peptide display on the surface of filamentous bacteriophage. Gene 171:49–51
Malik P, Perham RN (1997) Simultaneous display of different peptides on the surface of filamentous bacteriophage. Nucleic Acids Res 25:915–916
McCafferty J, Griffiths AD, Winter G, Chiswell DJ (1990) Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348:552–554
Minenkova OO, Ilyichev AA, Kishchenko GP, Petrenko VA (1993) Design of specific immunogens using filamentous phage as the carrier. Gene 128:85–88
Newton JR, Kelly KA, Mahmood U, Weissleder R, Deutscher SL (2006) In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice. Neoplasia 8:772–780
Park I, Choi IH, Kim SJ, Shin JS (2004) Peptide mimotopes of Neisseria meningitidis group B capsular polysaccharide. Yonsei Med J 45:755–758
Pasqualini R, Ruoslahti E (1996) Organ targeting in vivo using phage display peptide libraries. Nature 380:364–365
Poul MA, Marks JD (1999) Targeted gene delivery to mammalian cells by filamentous bacteriophage. J Mol Biol 288:203–211
Sapinoro R, Volcy K, Rodrigo WW, Schlesinger JJ, Dewhurst S (2008) Fc receptor-mediated, antibody-dependent enhancement of bacteriophage lambda-mediated gene transfer in mammalian cells. Virology 373:274–286
Sartorius R, Pisu P, D’Apice L, Pizzella L, Romano C, Cortese G, Giorgini A, Santoni A, Velotti F, De Berardinis P (2008) The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses. J Immunol 180:3719–3728
Sartorius R, Bettua C, D’Apice L, Caivano A, Trovato M, Russo D, Zanoni I, Granucci F, Mascolo D, Barba P, Pozzo G, De Berardinis P (2011) Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T-cell responses in the absence of adjuvants. Eur J Immunol 41:2573–2584
Schluesener HJ, Xianglin T (2004) Selection of recombinant phages binding to pathological endothelial and tumor cells of rat glioblastoma by in-vivo display. J Neurol Sci 224:77–82
Solomon B (2007) Active immunization against Alzheimer’s beta-amyloid peptide using phage display technology. Vaccine 25:3053–3056
Solomon B (2008) Filamentous bacteriophage as a novel therapeutic tool for Alzheimer’s disease treatment. J Alzheimers Dis 15:193–198
Urbanelli L, Ronchini C, Fontana L, Menard S, Orlandi R, Monaci P (2001) Targeted gene transduction of mammalian cells expressing the HER2/neu receptor by filamentous phage. J Mol Biol 313:965–976
van Houten NE, Scott JK (2005) Phage library for developing antibody-targeted diagnostics and vaccines. In: Sidhu SS (ed) Phage display in biotechnology and drug discovery. CRC Press, South San Francisco
van Houten NE, Henry KA, Smith GP, Scott JK (2010) Engineering filamentous phage carriers to improve focusing of antibody responses against peptides. Vaccine 28:2174–2185
Wan Y, Wu Y, Bian J, Wang XZ, Zhou W, Jia ZC, Tan Y, Zhou L (2001) Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine. Vaccine 19:2918–2923
Wan Y, Wu Y, Zhou J, Zou L, Liang Y, Zhao J, Jia Z, Engberg J, Bian J, Zhou W (2005) Cross-presentation of phage particle antigen in MHC class II and endoplasmic reticulum marker-positive compartments. Eur J Immunol 35:2041–2050
Wilkinson RA, Evans JR, Jacobs JM, Slunaker D, Pincus SH, Pinter A, Parkos CA, Burritt JB, Teintze M (2007) Peptides selected from a phage display library with an HIV-neutralizing antibody elicit antibodies to HIV gp120 in rabbits, but not to the same epitope. AIDS Res Hum Retroviruses 23:1416–1427
Willis AE, Perham RN, Wraith D (1993) Immunological properties of foreign peptides in multiple display on a filamentous bacteriophage. Gene 128:79–83
Work LM, Nicol CG, Denby L, Baker AH (2005) In vivo biopanning: a methodological approach to identifying novel targeting ligands for delivery of biological agents to the vasculature. Methods Mol Med 108:395–413
Wu Y, Wan Y, Bian J, Zhao J, Jia Z, Zhou L, Zhou W, Tan Y (2002) Phage display particles expressing tumor-specific antigens induce preventive and therapeutic anti-tumor immunity in murine p815 model. Int J Cancer 98:748–753
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Sartorius, R., Russo, D., D’Apice, L., De Berardinis, P. (2012). Filamentous Bacteriophages: An Antigen and Gene Delivery System. In: Baschieri, S. (eds) Innovation in Vaccinology. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4543-8_6
Download citation
DOI: https://doi.org/10.1007/978-94-007-4543-8_6
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4542-1
Online ISBN: 978-94-007-4543-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)